Global Human Chorionic Gonadotropin Market 2020-2025 : Increasing Demand Of Substitutes & Rising Number Of Market Players - Merck, Ferring, Fresenius Kabi

The growing demand for Human Chorionic Gonadotropin has provided a major boost to the Global Human Chorionic Gonadotropin Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and reach values of high millions by the end of the forecast period of 2019 up to 2023.

Global Human Chorionic Gonadotropin Market overview:

This Report covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Get Access to Report Sample @ https://www.businessindustryreports.com/sample-request/176926.

Some of observe Human Chorionic Gonadotropin belongs to the family of gonadotropin hormones and is naturally produced by the placenta. Human Chorionic Gonadotropin hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. Human Chorionic Gonadotropin triggers ovulation in women and assists in increasing the sperm count in men.

The Global Human Chorionic Gonadotropin Market is segmented on the basis of Product Type, Application, End Use Industry and Region. On the Basis of Product Type segment, the Human Chorionic Gonadotropin Market is sub segmented into Natural Source Extraction, Recombinant Technology.

Based on End Use Industry segment, the Human Chorionic Gonadotropin Market is sub segmented into Fertility Clinics, Research Institutions. The paradigm shift toward gonadotropin therapy for the treatment of several threatening diseases such as infertility, cryptorchidism, and others is expected to create lucrative opportunities for the expansion of the global Human Chorionic Gonadotropin market. The female infertility segment dominated the global market in 2017 and is anticipated to remain dominant throughout the forecast period. This is attributed to the rise in infertility-related problems such as polycystic ovary syndrome in females.

Some of the Human Chorionic Gonadotropin Market manufacturers involved in the market are Bristol Myers Squibb, Merck & Co, Ferring, Fresenius Kabi, Sun Pharmaceutical, Acquisitions and effective mergers are some of the strategies adopted by the Human Chorionic Gonadotropin Market manufacturers. New product launches and continuous technological innovations are the Human Chorionic Gonadotropin Market strategies adopted by the major players.

Human Chorionic Gonadotropin Market: Region-wise Outlook

Asia Pacific was a prominent market for Human Chorionic Gonadotropins in 2016. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income. Increased spending on home interiors is fuelling the Human Chorionic Gonadotropin market in Asia Pacific.

There are several manufacturers of Human Chorionic Gonadotropins in Europe and North America. In North America, the demand for Human Chorionic Gonadotropins is primarily driven by the residential sector. Improved standards of living and rising usage of Human Chorionic Gonadotropins for flooring purpose are anticipated to drive the market in North America.

Latest Industry Updates:

Merck:-known as MSD outside the United States and Canada, today announced results from the PURSUE Phase III study of 1,390 women, aged 35-42 years, for corifollitropin alfa, the company's investigational fertility treatment for controlled ovarian stimulation in women participating in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). The study met its primary endpoint of achieving vital pregnancy rates with data revealing that a single injection of 150 mcg of corifollitropin alfa was non-inferior to seven daily injections of 300 IU recombinant follicle stimulating hormone (rFSH). The study also evaluated key secondary endpoints of ongoing pregnancy rates and the number of oocytes (the female reproductive cell prior to fertilization) retrieved. Merck presented the results today at the 68th Annual Meeting of the American Society for Reproductive Medicine.

Merck remains on track to file a New Drug Application (NDA) for corifollitropin alfa with the U.S. Food and Drug Administration (FDA) in 2013. "Infertility is an issue many couples in the U.S. face," said Robert Boostanfar, M.D., study author, reproductive endocrinologist at HRC Fertility and clinical assistant professor at the Keck School of Medicine, Department of Obstetrics and Gynecology, University of Southern California. "If approved, corifollitropin alfa may provide clinicians with a different option for women undergoing controlled ovarian stimulation prior to IVF and ICSI.

Buy Human Chorionic Gonadotropin Market analysis & forecast 2020-2024 Report along with complete TOC@ https://www.businessindustryreports.com/buy-now/176926/single.

Get Best Discount On This Report @ https://www.businessindustryreports.com/check-discount/176926.

Table of Contents:

Global Human Chorionic Gonadotropin Market Report 2020

1 Human Chorionic Gonadotropin Definition

2 Global Human Chorionic Gonadotropin Market Major Player Share and Market Overview

3 Major Player Human Chorionic Gonadotropin Business Introduction

4 Global Human Chorionic Gonadotropin Market Segmentation (Region Level)

5 Global Human Chorionic Gonadotropin Market Segmentation (Product Type Level)

6 Global Human Chorionic Gonadotropin Market Segmentation (Industry Level)

7 Global Human Chorionic Gonadotropin Market Segmentation (Channel Level)

8 Human Chorionic Gonadotropin Market Forecast 2020-2024

................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.